|
No records
|
|
2 |
Chenderawasi S.; Dharma R.; Pohan H.T.; Dewi B.E.; Setiabudy R.; Suhendro; Aryati; Darmawan H.; Nainggolan L.; Iskandar A. |
Chenderawasi, Settrin (57221643087); Dharma, Rahajuningsih (12777817700); Pohan, Herdiman T. (23474782900); Dewi, Beti Ernawati (24076058600); Setiabudy, Rianto (6602316235); Suhendro (57215086884); Aryati (57209860388); Darmawan, Hardi (8581795700); Nainggolan, Leonard (23498394800); Iskandar, Agustin (37079172000) |
57221643087; 12777817700; 23474782900; 24076058600; 6602316235; 57215086884; 57209860388; 8581795700; 23498394800; 37079172000 |
Cut-off Value of HSPG for Early Marker of Plasma Leakage in Adult Dengue Patient |
2024 |
Indonesian Journal of Clinical Pathology and Medical Laboratory |
30 |
3 |
|
259 |
264 |
5 |
0 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85196512724&doi=10.24293%2fijcpml.v30i3.2221&partnerID=40&md5=c691867fc67c7f2904e3cec2a9cfba6b |
Community-Based Dengue Study, Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Department of Clinical Pathology, University of Indonesia, Jakarta, Indonesia; Department of Internal Medicine, University of Indonesia, Jakarta, Indonesia; Department of Microbiology, University of Indonesia, Jakarta, Indonesia; Department of Pharmacology, University of Indonesia, Jakarta, Indonesia; Department of Clinical Pathology, Airlangga University, Surabaya, Indonesia; Department of Physiology, University of Sriwijaya, Palembang, Indonesia; Department of Clinical Pathology, Brawijaya University, Malang, Indonesia |
Chenderawasi S., Community-Based Dengue Study, Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Dharma R., Department of Clinical Pathology, University of Indonesia, Jakarta, Indonesia; Pohan H.T., Department of Internal Medicine, University of Indonesia, Jakarta, Indonesia; Dewi B.E., Community-Based Dengue Study, Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Department of Microbiology, University of Indonesia, Jakarta, Indonesia; Setiabudy R., Department of Pharmacology, University of Indonesia, Jakarta, Indonesia; Suhendro, Department of Internal Medicine, University of Indonesia, Jakarta, Indonesia; Aryati, Department of Clinical Pathology, Airlangga University, Surabaya, Indonesia; Darmawan H., Department of Physiology, University of Sriwijaya, Palembang, Indonesia; Nainggolan L., Community-Based Dengue Study, Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia, Department of Internal Medicine, University of Indonesia, Jakarta, Indonesia; Iskandar A., Department of Clinical Pathology, Brawijaya University, Malang, Indonesia |
Plasma leakage is a state of increased vascular permeability due to loss of interendothelial junction and focal adhesion. Endothelium glycocalyx plays a major role in the pathogenesis of plasma leakage. Proteoglycans glycocalyx consists of heparan sulfate (HSPG) around 50-90%. Plasma leakage in dengue infection can be fatal and early detection is essential. This study aimed to determine the optimal cut-off value of HSPG levels for early marker of plasma leakage in dengue infection. The study was a retrospective cohort study as a part of the Community Based Dengue Study of the Faculty of Medicine, University of Indonesia, which was conducted between February 2010 and January 2011. Subjects were recruited by consecutive sampling. Dengue infection was confirmed by conventional PCR serotyping. Subjects were categorized into 2 groups, i.e. those with and without plasma leakage. Plasma leakage was confirmed by hemoconcentration or hypoalbuminemia or USG results. The level of HSPG was measured using the ELISA method from the first until the third day of the hospital admission. A total of 40 subjects were involved in this study, consisting of 21 with leakage and 19 without st nd leakage. The optimal cut-off level of HSPG as a marker of early plasma leakage in dengue infection patients on the 1 day, 2 rd day, and 3 day was was 2179.73 pg/mL, 2538.66 pg/mL, and 1294.06 pg/mL, respectively. HSPG could as an early marker of plasma leakage in dengue infection with an optimal cut-off value for each of the first 3 days of the patient's fever. A pediatric study was recommended to obtain the optimal cut-off value for HSPG. © 2024, Indonesian Association of Clinical Pathology and Laboratory Medicine. All rights reserved. |
Dengue; HSPG; plasma leakage marker |
|
Community Based Dengue Study Faculty of Medicine Universitas Indonesia |
This study was supported by the Community Based Dengue Study Faculty of Medicine Universitas Indonesia. |
Indonesian Association of Clinical Pathology and Laboratory Medicine |
24774685 |
|
|
Article |
#N/A |
#N/A |
#N/A |
|
|
|
26 |
Siregar G.O.; Harianja M.; Adella J.; Krismawati H.; Sundari E.S.; Ataupah M.R.; Laiskodat R.D.; Bøgh C.; Soebono H.; Grijsen M.L. |
Siregar, Gladys O. (58876649500); Harianja, Maria (58876435800); Adella, Jacklyn (58994793100); Krismawati, Hana (56572770100); Sundari, Evivana S. (58876435900); Ataupah, Messe R. (58993911900); Laiskodat, Ruth D. (58994354700); Bøgh, Claus (6602120205); Soebono, Hardyanto (6508242918); Grijsen, Marlous L. (25225113700) |
58876649500; 58876435800; 58994793100; 56572770100; 58876435900; 58993911900; 58994354700; 6602120205; 6508242918; 25225113700 |
Leprosy identified in Sumba Island, eastern Indonesia: elimination targets under threat |
2024 |
The Lancet Regional Health - Southeast Asia |
26 |
|
100409 |
|
|
|
0 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85190856063&doi=10.1016%2fj.lansea.2024.100409&partnerID=40&md5=4f24b635df4260f90f0d5f674d9efa33 |
Sumba Foundation, Sumba, Indonesia; Center of Health System and Strategy, Ministry of Health, Jakarta, Indonesia; Department of Dermatology and Venereology, Siloam Hospital, Kupang, Indonesia; Province Health Office, East Nusa Tenggara, Kupang, Indonesia; Department of Dermatology and Venereology, Gadjah Mada University, Yogyakarta, Indonesia; Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom |
Siregar G.O., Sumba Foundation, Sumba, Indonesia; Harianja M., Sumba Foundation, Sumba, Indonesia; Adella J., Sumba Foundation, Sumba, Indonesia; Krismawati H., Center of Health System and Strategy, Ministry of Health, Jakarta, Indonesia; Sundari E.S., Department of Dermatology and Venereology, Siloam Hospital, Kupang, Indonesia; Ataupah M.R., Province Health Office, East Nusa Tenggara, Kupang, Indonesia; Laiskodat R.D., Province Health Office, East Nusa Tenggara, Kupang, Indonesia; Bøgh C., Sumba Foundation, Sumba, Indonesia; Soebono H., Department of Dermatology and Venereology, Gadjah Mada University, Yogyakarta, Indonesia; Grijsen M.L., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom |
[No abstract available] |
|
awareness; disease burden; disease transmission; health care personnel; human; leprosy; multibacillary leprosy; nerve injury; Note; paucibacillary leprosy; polypharmacy; primary health care; skin care; teledermatology; telemedicine |
Wellcome Trust, WT; Sumba Foundation |
Funding text 1: The project was financially supported by the Wellcome Trust Africa Asia Programme Vietnam. The authors declare that they have no conflicts of interest. ; Funding text 2: We extend our sincere gratitude to all Sumba Foundation healthcare workers. We wish to acknowledge Ben Naafs for sharing his expertise on leprosy with the clinical team. |
Elsevier Ltd |
27723682 |
|
|
Note |
#N/A |
#N/A |
#N/A |
|
|
|
49 |
Gach M.W.; Lazarus G.; Simadibrata D.M.; Sinto R.; Saharman Y.R.; Limato R.; Nelwan E.J.; van Doorn H.R.; Karuniawati A.; Hamers R.L. |
Gach, Michael W. (57675752100); Lazarus, Gilbert (57214599425); Simadibrata, Daniel Martin (57202134322); Sinto, Robert (36099377100); Saharman, Yulia Rosa (55980934300); Limato, Ralalicia (57196224631); Nelwan, Erni J. (14527452900); van Doorn, H. Rogier (56941604800); Karuniawati, Anis (54886816200); Hamers, Raph L. (23034345900) |
57675752100; 57214599425; 57202134322; 36099377100; 55980934300; 57196224631; 14527452900; 56941604800; 54886816200; 23034345900 |
Antimicrobial resistance among common bacterial pathogens in Indonesia: a systematic review |
2024 |
The Lancet Regional Health - Southeast Asia |
26 |
|
100414 |
|
|
|
0 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85192810137&doi=10.1016%2fj.lansea.2024.100414&partnerID=40&md5=8b7941694224b5ac273f8fd664e75b48 |
Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; Department of Internal Medicine, Division of Tropical Medicine and Infectious Diseases, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Department of Clinical Microbiology, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Oxford University Clinical Research Unit, Hanoi, Viet Nam |
Gach M.W., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Lazarus G., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Simadibrata D.M., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States; Sinto R., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom, Department of Internal Medicine, Division of Tropical Medicine and Infectious Diseases, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Saharman Y.R., Department of Clinical Microbiology, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Limato R., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; Nelwan E.J., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Department of Internal Medicine, Division of Tropical Medicine and Infectious Diseases, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; van Doorn H.R., Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom, Oxford University Clinical Research Unit, Hanoi, Viet Nam; Karuniawati A., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Department of Clinical Microbiology, Dr. Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Hamers R.L., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom |
Background: The WHO Global Antimicrobial Resistance Surveillance System (GLASS) aims to describe antimicrobial resistance (AMR) patterns and trends in common bacterial pathogens, but data remain limited in many low and middle-income countries including Indonesia. Methods: We systematically searched Embase, PubMed and Global Health Database and three Indonesian databases for original peer-reviewed articles in English and Indonesian, published between January 1, 2000 and May 25, 2023, that reported antimicrobial susceptibility for the 12 GLASS target pathogens from human samples. Pooled AMR prevalence estimates were calculated for relevant pathogen-antimicrobial combinations accounting for the sampling weights of the studies (PROSPERO: CRD42019155379). Findings: Of 2182 search hits, we included 102 papers, comprising 19,517 bacterial isolates from hospitals (13,647) and communities (5870). In hospital settings, 21.6% of Klebsiella pneumoniae isolates, 18.3% of Escherichia coli isolates, 35.8% of Pseudomonas aeruginosa isolates and 70.7% of Acinetobacter baumannii isolates were carbapenem-resistant; 29.9% of Streptococcus pneumoniae isolates were penicillin-resistant; and 22.2% of Staphylococcus aureus isolates were methicillin-resistant. Hospital prevalence of carbapenem-resistant K. pneumoniae and E. coli, and penicillin-resistant S. pneumoniae increased over time. In communities, 28.3% of K. pneumoniae isolates and 15.7% of E. coli isolates were carbapenem-resistant, 23.9% of S. pneumoniae isolates were penicillin-resistant, and 11.1% of S. aureus isolates were methicillin-resistant. Data were limited for the other pathogens. Interpretation: AMR prevalence estimates were high for critical gram-negative bacteria. However, data were insufficient to draw robust conclusions about the full contemporary AMR situation in Indonesia. Implementation of national AMR surveillance is a priority to address these gaps and inform context-specific interventions. Funding: Wellcome Africa Asia Programme Vietnam. © 2024 The Author(s) |
Antimicrobial resistance; Antimicrobial susceptibility; Bacteria; GLASS; Indonesia; Systematic review |
amikacin; cefepime; cefoxitin; ceftazidime; cephalosporin; colistin; cotrimoxazole; doripenem; extended spectrum beta lactamase; fosfomycin; gentamicin; imipenem; meropenem; nitrofurantoin; oxacillin; piperacillin plus tazobactam; quinoline derived antiinfective agent; tigecycline; tobramycin; Acinetobacter baumannii; antibacterial activity; antibiotic resistance; antibiotic sensitivity; Article; bacterial load; bacterium isolation; carbapenem resistance; community acquired infection; disk diffusion; epsilometer test; Escherichia coli; geographic distribution; Haemophilus influenzae; hospital infection; human; Indonesia; infection risk; Klebsiella pneumoniae; matrix assisted laser desorption ionization time of flight mass spectrometry; meta analysis; methicillin resistance; methicillin res |
Kementerian Pendidikan, Kebudayaan, Riset, dan Teknologi, MECRT; Oxford University Clinical Academic Graduate School, OUCAGS; OUCRU; JPT Family Trust; Ministry of Education, Culture, Research, and Technology Republic of Indonesia; Wellcome Africa Asia Programme Vietnam, (106680/Z/14/Z); Lembaga Pengelola Dana Pendidikan, LPDP, (202101182688); Lembaga Pengelola Dana Pendidikan, LPDP |
Funding text 1: Wellcome Africa Asia Programme Vietnam.None. Funding statement: This work was funded by the Wellcome Africa Asia Programme Vietnam (106680/Z/14/Z), which also supports RLH and HRVD. MG was supported by the JPT Family Trust award and Oxford University Clinical Academic Graduate School. RL was supported by an OUCRU Prize Studentship and a Nuffield Dept of Medicine Tropical Network Fu |
Elsevier Ltd |
27723682 |
|
|
Article |
#N/A |
#N/A |
#N/A |
|
|
|
62 |
Thanh H.N.; Sutrisni I.A.; Rijal S.; Pandey A.; Tran T.P.; Dien R.; Thi Hong Y.N.; Timoria D.; Friska D.; Kekalih A.; Bogh C.; Karkey A.; Hamers R.L.; Chambers M.; Lewycka S.; Van Nuil J.I. |
Thanh, Ha Nguyen (57211920045); Sutrisni, Ida Ayu (58141717800); Rijal, Samita (57317769000); Pandey, Aakriti (59036083500); Tran, Thao Phuong (57195572453); Dien, Ragil (57233234500); Thi Hong, Yen Nguyen (58897234000); Timoria, Diana (58141577600); Friska, Dewi (57202805330); Kekalih, Aria (55633562200); Bogh, Claus (6602120205); Karkey, Abhilasha (26532900700); Hamers, Raph L. (23034345900); Chambers, Mary (57216076926); Lewycka, Sonia (57212496031); Van Nuil, Jennifer Ilo (37103111300) |
57211920045; 58141717800; 57317769000; 59036083500; 57195572453; 57233234500; 58897234000; 58141577600; 57202805330; 55633562200; 6602120205; 26532900700; 23034345900; 57216076926; 57212496031; 37103111300 |
Social cohesion among healthcare workers during COVID-19: Qualitative research in Indonesia, Nepal, and Vietnam |
2024 |
SSM - Qualitative Research in Health |
5 |
|
100404 |
|
|
|
0 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85185552584&doi=10.1016%2fj.ssmqr.2024.100404&partnerID=40&md5=3b71ab82b6f8b0c8cec988c20d993d5d |
Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Oxford University Clinical Research Unit, Kathmandu, Nepal; Oxford University Clinical Research Unit, Hanoi, Viet Nam; Sumba Foundation, Sumba, Indonesia; Department of Community Medicine, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Centre for Tropical Medicine and Global Health, Nuffield Dept of Medicine, University of Oxford, Oxford, United Kingdom |
Thanh H.N., Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Sutrisni I.A., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Rijal S., Oxford University Clinical Research Unit, Kathmandu, Nepal; Pandey A., Oxford University Clinical Research Unit, Kathmandu, Nepal; Tran T.P., Oxford University Clinical Research Unit, Hanoi, Viet Nam; Dien R., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Thi Hong Y.N., Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam; Timoria D., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Sumba Foundation, Sumba, Indonesia; Friska D., Department of Community Medicine, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Kekalih A., Department of Community Medicine, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Bogh C., Sumba Foundation, Sumba, Indonesia; Karkey A., Oxford University Clinical Research Unit, Kathmandu, Nepal; Hamers R.L., Oxford University Clinical Research Unit Indonesia, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Centre for Tropical Medicine and Global Health, Nuffield Dept of Medicine, University of Oxford, Oxford, United Kingdom; Chambers M., Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam, Centre for Tropical Medicine and Global Health, Nuffield Dept of Medicine, University of Oxford, Oxford, United Kingdom; Lewycka S., Oxford University Clinical Research Unit, Hanoi, Viet Nam, Centre for Tropical Medicine and Global Health, Nuffield Dept of Medicine, University of Oxford, Oxford, United Kingdom; Van Nuil J.I., Oxford University Clinical Research Unit, Ho Chi Minh City, Viet Nam, Centre for Tropical Medicine and Global Health, Nuffield Dept of Medicine, University of Oxford, Oxford, United Kingdom |
Existing literature has portrayed numerous challenges that healthcare workers (HCWs) faced during the COVID-19 pandemic, such as heightened risks of transmission against the scarcity of protective equipment, burgeoning workload, and emotional distress, to name a few. However, most studies explored HCWs' experiences at the individual level rather than examining the collective responses. Exploring these experiences could reveal the social-cultural locality of the pandemic while identifying the system constraints in public health emergencies. As part of a mixed-method study on COVID-19 pandemic impacts, we analysed qualitative interview data with 129 HCWs and health-related staff to explore their experiences during the pandemic between 2020 and 2021 in Vietnam, Indonesia, and Nepal. Using Bahers' sociological framework, Community of Fate, we describe five themes reflecting the formation of a community of HCWs and the social cohesion underlying their efforts to survive hardship. The first three themes characterise the HCW community of fate, including (1) Recognition of extreme work-related danger, (2) physical and figurative closures where HCWs restrict themselves from the outside world, (3) chronic ordeals with overwhelming workload and responsibilities, encompassing recurrent mental health challenges. Against such extreme hardship, cohesive bonding and social resilience are reflected through two additional themes: (4) a mutual sense of moral and professional duty to protect communities, (5) the vertical and horizontal convergence among HCWs across levels and among government departments. We discuss these HCWs’ challenges in relation to systemic vulnerabilities while advocating for increasing investment in public health and collaboration across government sectors to prepare for emergency situations. © 2024 The Authors |
COVID-19; Healthcare workers; Indonesia; Nepal; Qualitative; Social cohesion; Vietnam |
adult; Article; coronavirus disease 2019; female; health care personnel; human; Indonesia; male; mental health; Nepal; pandemic; public health; qualitative research; risk factor; social cohesion; social resilience; Viet Nam; workload |
Higher Education Innovation Fund; Urgent Response Fund; Wellcome Trust, WT, (106680); Wellcome Trust, WT; Economic and Social Research Council, ESRC |
We would like to acknowledge all the participants who have participated in the SPEAR Study as well as the full SPEAR study team. We also would like to acknowledge all of our collaborators across the study sites as the research would not have been possible without their support. This study was funded through Wellcome (Programme core funding and Provisions for Public engagement 106680). This publica |
Elsevier Ltd |
26673215 |
|
|
Article |
#N/A |
#N/A |
#N/A |
|
|
|
68 |
Karyanti M.R.; Uiterwaal C.S.P.M.; Hadinegoro S.R.; Widyahening I.S.; Saldi S.R.F.; Heesterbeek J.A.P.H.; Hoes A.W.; Bruijning-Verhagen P. |
Karyanti, Mulya Rahma (56290680800); Uiterwaal, Cuno S P M (59148037600); Hadinegoro, Sri Rezeki (56893685800); Widyahening, Indah Suci (54893154400); Saldi, Siti Rizny F (55201904000); Heesterbeek, J A P Hans (59134733500); Hoes, Arno W. (35370614300); Bruijning-Verhagen, Patricia (55175644800) |
56290680800; 59148037600; 56893685800; 54893154400; 55201904000; 59134733500; 35370614300; 55175644800 |
The Value of Warning Signs From the WHO 2009 Dengue Classification in Detecting Severe Dengue in Children |
2024 |
The Pediatric infectious disease journal |
43 |
7 |
|
630 |
634 |
4 |
0 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85196767536&doi=10.1097%2fINF.0000000000004326&partnerID=40&md5=04c0ef35f4c83ec1bb4da39449b609c4 |
From the Department of Child Health, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands; Department of Community Medicine, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Clinical Epidemiology and Evidence-Based Medicine Unit, Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands |
Karyanti M.R., From the Department of Child Health, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands; Uiterwaal C.S.P.M., Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands; Hadinegoro S.R., From the Department of Child Health, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Widyahening I.S., Department of Community Medicine, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Saldi S.R.F., Clinical Epidemiology and Evidence-Based Medicine Unit, Cipto Mangunkusumo Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia; Heesterbeek J.A.P.H., Department of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands; Hoes A.W., Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands; Bruijning-Verhagen P., Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands |
BACKGROUND: World Health Organization proposed 7 warning signs to identify the risk of severe dengue in 2009. This study aimed to evaluate the value of these warning signs in detecting severe dengue in children. MATERIAL AND METHODS: A cross-sectional study was conducted utilizing data of children with clinical dengue infection obtained from medical records between January 2009 and December 2018 in Jakarta. Children with confirmed dengue were analyzed and stratified into 3 age groups: infants less than 1 year old, children 1-14 years and adolescents 15-18 years of age. Positive predictive value, negative predictive value (NPV), sensitivity and specificity of each warning sign present or absent on admission in detecting severe dengue were computed. RESULTS: Six hundred ninety-nine children with clinical dengue infection were enrolled, among whom 614 (87.8%) had confirmed dengue infection, either by antigen or antibody serological tests. Severe dengue occurred in 211/614 (34.4%) cases. In infants, important warning signs on admission to detect or exclude severe dengue were liver enlargement (NPV 80.8%) and clinical fluid accumulation (NPV 75%). In children and adolescents, warning sign with highest NPV (in children 76.6% and in adolescents 91.9%) was increase in hematocrit concurrent with a rapid decrease in platelet count. Other warning signs with high NPV values in children were abdominal pain (72%), vomiting (70%), clinical fluid accumulation (69.3%), and in adolescents' abdominal pain (80.7%), vomiting (75.7%), clinical fluid accumulation (82.7%). NPVs increase with more than 1 warning sign in all age groups. CONCLUSION: In infants, liver enlargement or clinical fluid accumulation are important warning signs for severe dengue, when both are absent, severe dengue is unlikely. In older children and adolescents, an increase in hematocrit with the concurrent rapid decrease in platelet count is most discriminative; followed by the absence of abdominal pain, vomiting or fluid accumulation are unlikely severe dengue. Copyright © 2024 The Author(s). Published by Wolters Kluwer Health, Inc. |
|
Adolescent; Child; Child, Preschool; Cross-Sectional Studies; Female; Humans; Infant; Male; Sensitivity and Specificity; Severe Dengue; World Health Organization; adolescent; child; cross-sectional study; diagnosis; female; human; infant; male; preschool child; sensitivity and specificity; severe dengue; World Health Organization |
|
|
|
15320987 |
|
38652064 |
Article |
#N/A |
#N/A |
#N/A |
|
|
|
78 |
Muharram F.R.; Multazam C.E.C.Z.; Harmadha W.S.; Andrianto A.; Salsabilla S.A.; Dakota I.; Andriantoro H.; Firman D.; Montain M.M.; Prakoso R.; Anggraeni D. |
Muharram, Farizal Rizky (57216980622); Multazam, Chaq El Chaq Zamzam (58251801300); Harmadha, Wigaviola Socha (58251171000); Andrianto, Andrianto (57216770187); Salsabilla, Senitza Anisa (57214878997); Dakota, Iwan (55796663700); Andriantoro, Hananto (55037171500); Firman, Doni (54898724100); Montain, Maya Marinda (58199735300); Prakoso, Radityo (57192893243); Anggraeni, Dilla (59119915800) |
57216980622; 58251801300; 58251171000; 57216770187; 57214878997; 55796663700; 55037171500; 54898724100; 58199735300; 57192893243; 59119915800 |
Distribution of catheterisation laboratories in Indonesia 2017–2022: a nationwide survey |
2024 |
The Lancet Regional Health - Southeast Asia |
26 |
|
100418 |
|
|
|
0 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85192701300&doi=10.1016%2fj.lansea.2024.100418&partnerID=40&md5=6aba71af307febe729dc45e1d098eab7 |
Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States; National Heart and Lung Institute, Imperial College London, London, United Kingdom; Faculty of Medicine, Airlangga University, Soetomo General Hospital, Surabaya, Indonesia; Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Centre Harapan Kita, West Jakarta, Indonesia |
Muharram F.R., Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, United States; Multazam C.E.C.Z., National Heart and Lung Institute, Imperial College London, London, United Kingdom; Harmadha W.S., National Heart and Lung Institute, Imperial College London, London, United Kingdom; Andrianto A., Faculty of Medicine, Airlangga University, Soetomo General Hospital, Surabaya, Indonesia; Salsabilla S.A., Faculty of Medicine, Airlangga University, Soetomo General Hospital, Surabaya, Indonesia; Dakota I., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Centre Harapan Kita, West Jakarta, Indonesia; Andriantoro H., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Centre Harapan Kita, West Jakarta, Indonesia; Firman D., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Centre Harapan Kita, West Jakarta, Indonesia; Montain M.M., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Centre Harapan Kita, West Jakarta, Indonesia; Prakoso R., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Centre Harapan Kita, West Jakarta, Indonesia; Anggraeni D., Department of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia, National Cardiovascular Centre Harapan Kita, West Jakarta, Indonesia |
Background: Geographical terrains of Indonesia pose a major hindrance to transportation. The difficulty of transportation affects the provision of acute time-dependent therapy such as percutaneous coronary intervention (PCI). Also, Indonesia's aging population would have a significant impact on the prevalence of acute coronary syndrome in the next decade. Therefore, the analysis and enhancement of cardiovascular care are crucial. The catheterisation laboratory performs PCI procedures. In the current study, we mapped the number and distribution of catheterisation laboratories in Indonesia. Methods: A direct survey was used to collect data related to catheterisation laboratory locations in July 2022. The population data was sourced from the Ministry of Home Affairs. The recent growth of catheterisation laboratories was examined and evaluated based on geographical areas. The main instruments for comparing regions and changes throughout time are the ratio of catheterisation laboratories per 100,000 population and the Gini index (a measure of economic and healthcare inequality. Gini index ranges from 0 to 1, with greater values indicating more significant levels of inequality). Regression analysis was carried out to see how the number of catheterisation laboratories was affected by health demand (prevalence) and economic capacity (Gross Domestic Regional Product [GDRP] per Capita). Findings: The number of catheterisation laboratories in Indonesia significantly increased from 181 to 310 during 2017–2022, with 44 of the 119 new labs built in an area that did not have one. Java has the most catheterisation laboratories (208, 67%). The catheterisation laboratory ratio in the provinces of Indonesia ranges from 0.0 in West Papua and Maluku to 4.46 in Jakarta; the median is 1.09 (IQR 0.71–1.18). The distribution remains a problem, as shown by the high catheterisation laboratory Gini index (0.48). Regression shows that distribution of catheterisation laboratories was significantly affected by GDRP and the prevalence of heart disease. Interpretation: The number of catheterisation laboratories in Indonesia has increased significantly recently, however, maldistribution remains a concern. To improve Indonesia's cardiovascular emergency services, future development of catheterisation laboratories must be better planned considering the facility's accessibility and density. Funding: Airlangga Research Fund - Universitas Airlangga. © 2024 The Authors |
Acute coronary syndrome; Cardiovascular Disease; Cath lab; Geospatial analysis; Percutaneous coronary intervention |
acute coronary syndrome; Article; cardiologist; cardiovascular emergency; catheterization; cross-sectional study; economic inequality; emergency health service; geographic distribution; geographic mapping; Gini coefficient; gross domestic regional product; gross national product; health care access; health care facility; health care need; health care survey; health disparity; health infrastructure; heart disease; human; incidence; Indonesia; Irian Jaya; ischemic heart disease; Jakarta; laboratory; low income country; Maluku; middle income country; percutaneous coronary intervention; population research; prevalence; purchasing power; ST segment elevation myocardial infarction |
Airlangga Research Fund - Universitas Airlangga |
We are grateful to Dr. Basuni and Dr. Isman Firdaus for their time and advice in writing this study. We are grateful Airlangga Research Fund - Universitas Airlangga for providing financial support. |
Elsevier Ltd |
27723682 |
|
|
Article |
#N/A |
#N/A |
#N/A |
|
|
|
80 |
Pasaribu M.M.B.; Ibrahim N.A.A.; Satriani D. |
Pasaribu, Merci Monica Br (57391787700); Ibrahim, Naufal Arkan Abiyyu (57221410260); Satriani, Dayu (59180733500) |
57391787700; 57221410260; 59180733500 |
Ultra-Low Anti-Müllerian Hormone Levels in Recurrent Cystic Ovarian Neoplasm: A Case Report |
2024 |
Indonesian Journal of Clinical Pathology and Medical Laboratory |
30 |
3 |
|
295 |
298 |
3 |
0 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85196488429&doi=10.24293%2fijcpml.v30i3.1940&partnerID=40&md5=4460aa5b4b467fc2db760086a56fe828 |
Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Pasaribu M.M.B., Department of Clinical Pathology, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia; Ibrahim N.A.A., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Satriani D., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Fertility has been a major issue in the management of cystic ovarian neoplasm. This case report presents an extreme case of ultra-low AMH levels in a young female with recurrent cystic ovarian neoplasm and analyzes the potential causes. A twenty-two-year-old female presented with stomach discomfort. The patient had undergone two surgeries for ovarian neoplasm within the last six years. The patient had another abdominal lump suspected to be a residual tumor mass. After further examination, the patient was diagnosed with cystic ovarian neoplasm. The laboratory findings showed low T4 levels, increased TSH levels, and ultra-low AMH levels (0.023 ng/mL). Management of cystic ovarian neoplasm should concern the effect on fertility. The AMH level can be used for pre-treatment counseling in these patients. © 2024, Indonesian Association of Clinical Pathology and Laboratory Medicine. All rights reserved. |
case report; fertility; ovarian cysts; ovarian neoplasm; Αnti-Müllerian hormone |
|
|
|
Indonesian Association of Clinical Pathology and Laboratory Medicine |
24774685 |
|
|
Article |
#N/A |
#N/A |
#N/A |
|
|
|
86 |
Febrian R.; Kumalawati J.; Putri N.D.; Luciana L.; Kekalih A. |
Febrian, Rivaldi (58970931500); Kumalawati, July (6504406695); Putri, Nina Dwi (57200573842); Luciana, Linny (59180731800); Kekalih, Aria (55633562200) |
58970931500; 6504406695; 57200573842; 59180731800; 55633562200 |
The Impact of Cycle Threshold Value in Influencing the Performance of COVID-19 Antigen |
2024 |
Indonesian Journal of Clinical Pathology and Medical Laboratory |
30 |
3 |
|
269 |
274 |
5 |
0 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85196533978&doi=10.24293%2fijcpml.v30i3.2217&partnerID=40&md5=1d591b730f053bafbe9ee8ef4006fdc9 |
Department of Clinical Pathology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Department of Child Health, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Department of Clinical Pathology, Faculty of Medicine, Krida Wacana Christian University, Jakarta, Indonesia; Department of Community Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia |
Febrian R., Department of Clinical Pathology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Kumalawati J., Department of Clinical Pathology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Putri N.D., Department of Child Health, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia; Luciana L., Department of Clinical Pathology, Faculty of Medicine, Krida Wacana Christian University, Jakarta, Indonesia; Kekalih A., Department of Community Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia |
COVID-19 antigen is an alternative test for detecting SARS-CoV-2 infection. Viral load represented by the Cycle Threshold (CT) in the Real-Time Reverse Transcriptase Polymerase Chain Reaction (rRT-PCR) affects the diagnostic performance of the test. Higher CT values result in reduced sensitivity of the SARS-CoV-2 antigen. The main objective of this study was to determine the highest CT value in rRT-PCR that still yielded reactive results in the COVID-19 antigen test. This cross-sectional study was conducted at the Fever Outpatient Clinic in Dr. Cipto Mangunkusumo Hospital from July 2020 to June 2021. Two hundred and thirty-five naso-oropharyngeal swabs were taken from patients with confirmed and suspected COVID-19 diagnoses. About 24.7% of subjects were tested positive. The median highest CT value giving reactive COVID-19 antigen results was 28.22 (13.33-39.16), while the median CT value for non-reactive antigen results was 34.45 (26.08-39.65). At a CT value ≤ 40, the COVID-19 antigen test demonstrated 63.8% sensitivity, 99.4% specificity, 89.3% Negative Predictive Value (NPV), and 97.4% Positive Predictive Value (PPV). At the CT value ≤ 25, the test showed 92.3% sensitivity, 99.4% specificity, 99.4% NPV, 92.3% PPV, 163.4 LR+, and 0.1 LR-. The identified cut-off point for the CT value was 29.82, with a sensitivity of 64.9% and specificity of 81%. In conclusion, COVID-19 antigen is a valuable test for screening patients with symptoms of SARS-CoV-2 infection. Understanding the influence of cycle threshold can enhance the interpretation and reliability of the antigen test. © 2024, Indonesian Association of Clinical Pathology and Laboratory Medicine. All rights reserved. |
COVID-19 antigen; Cycle threshold |
|
|
|
Indonesian Association of Clinical Pathology and Laboratory Medicine |
24774685 |
|
|
Article |
#N/A |
#N/A |
#N/A |
|
|
|
115 |
Lesmana C.R.A.; Kalista K.F.; Nababan S.H.H.; Kurniawan J.; Jasirwan C.O.M.; Sulaiman A.S.; Hasan I.; Gani R.A. |
Lesmana, Cosmas R. A. (8977683000); Kalista, Kemal F. (57200425631); Nababan, Saut H. H. (57205443199); Kurniawan, Juferdy (57193251655); Jasirwan, Chyntia O. M. (55192478000); Sulaiman, Andri S. (57833687400); Hasan, Irsan (12776850800); Gani, Rino A. (23495930300) |
8977683000; 57200425631; 57205443199; 57193251655; 55192478000; 57833687400; 12776850800; 23495930300 |
Innovations in endoscopic ultrasound for portal hypertension and its role in managing complications in clinical practice: Lessons learned from a tertiary referral public hospital |
2024 |
Portal Hypertension and Cirrhosis |
3 |
1 |
|
31 |
35 |
4 |
0 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195481233&doi=10.1002%2fpoh2.74&partnerID=40&md5=5a4003bd2977a62caf2d218e0019a7b1 |
Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta, Indonesia; Digestive Disease & GI Oncology Center, Medistra Hospital, Jakarta, Indonesia; Gastrointestinal Cancer Center, MRCCC Siloam Semanggi Hospital, Jakarta, Indonesia |
Lesmana C.R.A., Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta, Indonesia, Digestive Disease & GI Oncology Center, Medistra Hospital, Jakarta, Indonesia, Gastrointestinal Cancer Center, MRCCC Siloam Semanggi Hospital, Jakarta, Indonesia; Kalista K.F., Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta, Indonesia; Nababan S.H.H., Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta, Indonesia, Gastrointestinal Cancer Center, MRCCC Siloam Semanggi Hospital, Jakarta, Indonesia; Kurniawan J., Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta, Indonesia; Jasirwan C.O.M., Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta, Indonesia; Sulaiman A.S., Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta, Indonesia; Hasan I., Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta, Indonesia; Gani R.A., Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta, Indonesia |
Portal hypertension (PH) poses significant challenges. This paper presents an innovative study on the utilization of endoscopic ultrasound (EUS) for both the diagnosis and management of PH. Conducted at Dr. Cipto Mangunkusumo National General Hospital in Jakarta, this retrospective case series included patients diagnosed with PH through clinical examination, imaging evaluation, and esophagogastroduodenoscopy. Exclusion criteria comprised a history of reduced blood consumption within the last 5 days, hepatocellular carcinoma, massive ascites, or elevated international normalized ratio (>1.4). EUS-guided portal pressure gradient (PPG) measurements were performed using an innovative standard manometer. The study involved 15 patients, with 14 having liver cirrhosis and 1 diagnosed with Budd–Chiari syndrome. Among them, nine patients experienced bleeding due to gastroesophageal varices. Small and large esophageal varices were identified in four and eight patients, respectively. Gastroesophageal varices type 1 were observed in two patients, and type 2 in four patients. Isolated gastric fundal varices type 1 were present in one patient. Based on EUS-PPG measurements, 14 patients exhibited clinically significant portal hypertension. Seven patients underwent endoscopic band ligation and three underwent EUS-guided cyanoacrylate injection during the same session as the EUS-PPG measurement procedure. Notably, no adverse events, such as abdominal pain, perforation, or bleeding were observed during or after the procedure. EUS emerges as a promising and accurate tool for both diagnosis and management. © 2024 The Authors. Portal Hypertension & Cirrhosis published by John Wiley & Sons Ltd on behalf of Chinese Medical Association. |
cyanoacrylate injection; endoscopic ultrasound; liver cirrhosis; portal hypertension; portal pressure gradient |
|
|
|
John Wiley and Sons Inc |
27705838 |
|
|
Article |
#N/A |
#N/A |
#N/A |
|
|
|
119 |
Wardak M.F.; Rahimi A.; Lucero-Prisno D.E., III; Miranda A.V. |
Wardak, Mohammad Faisal (57356793500); Rahimi, Ali (57356721300); Lucero-Prisno, Don Eliseo (56051373800); Miranda, Adriana Viola (57222664687) |
57356793500; 57356721300; 56051373800; 57222664687 |
Overcoming barriers to COVID-19 herd immunity in Afghanistan |
2024 |
Public Health Challenges |
3 |
1 |
e161 |
|
|
|
0 |
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85195193453&doi=10.1002%2fpuh2.161&partnerID=40&md5=5e5f7a155ffc066a7d1fbab7749503e5 |
Scientific Research Center, Jami University, Herat, Afghanistan; Faculty of Medicine, Jami University, Herat, Afghanistan; Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom; Faculty of Management and Development Studies, University of the Philippines Open University, Laguna, Los Baños, Philippines; Faculty of Public Health, Mahidol University, Bangkok, Thailand; Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Wardak M.F., Scientific Research Center, Jami University, Herat, Afghanistan; Rahimi A., Scientific Research Center, Jami University, Herat, Afghanistan, Faculty of Medicine, Jami University, Herat, Afghanistan; Lucero-Prisno D.E., III, Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom, Faculty of Management and Development Studies, University of the Philippines Open University, Laguna, Los Baños, Philippines, Faculty of Public Health, Mahidol University, Bangkok, Thailand; Miranda A.V., Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia |
Afghanistan faces numerous obstacles in its endeavor to achieve herd immunity against COVID-19. Inadequate resources, vaccine hesitancy, and the new government's lack of international recognition have impeded the country and harmed vaccine procurement and distribution. Although the recent power shift has led to a more secure situation, the country's vaccination coverage remains at 44.05% as of November 26, 2023. The main hurdles to herd immunity include limited vaccine accessibility, extensive vaccine hesitancy, an inefficient cold chain system causing high vaccine wastage rates, substandard service delivery, recent restrictions on women's healthcare access, low health literacy, and a weakened economy owing to decades of conflict and international sanctions. This article assesses vaccination progress, and herd immunity barriers, and provides solutions to overcome them in Afghanistan. A comprehensive approach is required, which involves enhancing public awareness of the benefits of vaccination, debunking vaccine-related misconceptions through the media, expanding vaccine accessibility especially in remote areas, increasing vaccination personnel, promoting the cold chain and delivery system, reversing the ban on women's education and employment, boosting the economy, and increasing the inflow of humanitarian aid by lifting international sanctions. Successfully implementing these measures can help Afghanistan overcome obstacles to herd immunity, leading the country toward a safer and healthier future. © 2024 The Authors. Public Health Challenges published by John Wiley & Sons Ltd. |
Afghanistan; COVID-19; herd immunity; pandemic; vaccination |
|
|
|
John Wiley and Sons Inc |
27692450 |
|
|
Note |
#N/A |
#N/A |
#N/A |
|
|
